Cardiol Therapeutics (CRDL) Q4 2023 Earnings
CRDL·Reported May 14, 2024·Before market open
Diluted EPS came in at $-0.10, missed the $-0.06 consensus by $0.04.
Diluted EPS
$-0.10missed by $0.04
Consensus: $-0.06
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2023 Earnings FAQ
Common questions about Cardiol Therapeutics's Q4 2023 earnings report.
Cardiol Therapeutics (CRDL) reported Q4 2023 earnings on May 14, 2024 before market open.
Cardiol Therapeutics reported diluted EPS of $-0.10 for Q4 2023.
EPS missed the consensus estimate of $-0.06 by $0.04.